These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 12860165

  • 1. Lymph node histology in head and neck cancer: impact of immunotherapy with IRX-2.
    Meneses A, Verastegui E, Barrera JL, de la Garza J, Hadden JW.
    Int Immunopharmacol; 2003 Aug; 3(8):1083-91. PubMed ID: 12860165
    [Abstract] [Full Text] [Related]

  • 2. Histologic findings in patients with head and neck squamous cell carcinoma receiving perilymphatic natural cytokine mixture (IRX-2) prior to surgery.
    Meneses A, Verastegui E, Barrera JL, Zinser J, de la Garza J, Hadden JW.
    Arch Pathol Lab Med; 1998 May; 122(5):447-54. PubMed ID: 9593347
    [Abstract] [Full Text] [Related]

  • 3. A trial of IRX-2 in patients with squamous cell carcinomas of the head and neck.
    Hadden J, Verastegui E, Barrera JL, Kurman M, Meneses A, Zinser JW, de la Garza J, Hadden E.
    Int Immunopharmacol; 2003 Aug; 3(8):1073-81. PubMed ID: 12860164
    [Abstract] [Full Text] [Related]

  • 4. Immunological approach in the evaluation of regional lymph nodes of patients with squamous cell carcinoma of the head and neck.
    Verastegui E, Morales R, Barrera JL, Müeller A, Guzman B, Meneses A, Alfaro G.
    Clin Immunol; 2002 Jan; 102(1):37-47. PubMed ID: 11781066
    [Abstract] [Full Text] [Related]

  • 5. Intratumoral recombinant human interleukin-12 administration in head and neck squamous cell carcinoma patients modifies locoregional lymph node architecture and induces natural killer cell infiltration in the primary tumor.
    van Herpen CM, van der Laak JA, de Vries IJ, van Krieken JH, de Wilde PC, Balvers MG, Adema GJ, De Mulder PH.
    Clin Cancer Res; 2005 Mar 01; 11(5):1899-909. PubMed ID: 15756016
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A natural cytokine mixture (IRX-2) and interference with immune suppression induce immune mobilization and regression of head and neck cancer.
    Verastegui E, Barrera JL, Zinser J, Del Rio R, Meneses A, De La Garza J, Hadden JW.
    Int J Immunopharmacol; 1997 Mar 01; 19(11-12):619-27. PubMed ID: 9669202
    [Abstract] [Full Text] [Related]

  • 8. The effect of leukocyte interleukin injection (Multikine) treatment on the peritumoral and intratumoral subpopulation of mononuclear cells and on tumor epithelia: a possible new approach to augmenting sensitivity to radiation therapy and chemotherapy in oral cancer--a multicenter phase I/II clinical Trial.
    Tímár J, Forster-Horváth C, Lukits J, Döme B, Ladányi A, Remenár E, Kásler M, Bencsik M, Répássy G, Szabó G, Velich N, Suba Z, Elõ J, Balatoni Z, Bajtai A, Chretien P, Talor E.
    Laryngoscope; 2003 Dec 01; 113(12):2206-17. PubMed ID: 14660929
    [Abstract] [Full Text] [Related]

  • 9. Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer?
    McHam SA, Adelstein DJ, Rybicki LA, Lavertu P, Esclamado RM, Wood BG, Strome M, Carroll MA.
    Head Neck; 2003 Oct 01; 25(10):791-8. PubMed ID: 12966502
    [Abstract] [Full Text] [Related]

  • 10. Contralateral lymph neck node metastasis of squamous cell carcinoma of the oral cavity: a retrospective analytic study in 315 patients.
    González-García R, Naval-Gías L, Rodríguez-Campo FJ, Sastre-Pérez J, Muñoz-Guerra MF, Gil-Díez Usandizaga JL.
    J Oral Maxillofac Surg; 2008 Jul 01; 66(7):1390-8. PubMed ID: 18571022
    [Abstract] [Full Text] [Related]

  • 11. Combination immunotherapy of squamous cell carcinoma of the head and neck: a phase 2 trial.
    Barrera JL, Verastegui E, Meneses A, Zinser J, de la Garza J, Hadden JW.
    Arch Otolaryngol Head Neck Surg; 2000 Mar 01; 126(3):345-51. PubMed ID: 10722007
    [Abstract] [Full Text] [Related]

  • 12. Histopathologic validation of the sentinel node concept in oral and oropharyngeal squamous cell carcinoma.
    Nieuwenhuis EJ, van der Waal I, Leemans CR, Kummer A, Pijpers R, Castelijns JA, Brakenhoff RH, Snow GB.
    Head Neck; 2005 Feb 01; 27(2):150-8. PubMed ID: 15627261
    [Abstract] [Full Text] [Related]

  • 13. A phase 1 safety study of an IRX-2 regimen in patients with squamous cell carcinoma of the head and neck.
    Freeman SM, Franco JL, Kenady DE, Baltzer L, Roth Z, Brandwein HJ, Hadden JW.
    Am J Clin Oncol; 2011 Apr 01; 34(2):173-8. PubMed ID: 20539208
    [Abstract] [Full Text] [Related]

  • 14. Immunodeficiency and cancer: prospects for correction.
    Hadden JW.
    Int Immunopharmacol; 2003 Aug 01; 3(8):1061-71. PubMed ID: 12860163
    [Abstract] [Full Text] [Related]

  • 15. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer.
    Argiris A, Stenson KM, Brockstein BE, Mittal BB, Pelzer H, Kies MS, Jayaram P, Portugal L, Wenig BL, Rosen FR, Haraf DJ, Vokes EE.
    Head Neck; 2004 May 01; 26(5):447-55. PubMed ID: 15122662
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Control of nodal metastases in squamous cell head and neck cancer treated by radiation therapy or chemoradiation.
    Vergeer MR, Doornaert P, Leemans CR, Buter J, Slotman BJ, Langendijk JA.
    Radiother Oncol; 2006 Apr 01; 79(1):39-44. PubMed ID: 16632006
    [Abstract] [Full Text] [Related]

  • 18. Lymphoid subpopulation changes in regional lymph nodes in squamous head and neck cancer.
    Saxon A, Portis J.
    Cancer Res; 1977 Apr 01; 37(4):1154-8. PubMed ID: 300279
    [Abstract] [Full Text] [Related]

  • 19. Patterns of regional and distant metastasis in patients with eyelid and periocular squamous cell carcinoma.
    Faustina M, Diba R, Ahmadi MA, Esmaeli B.
    Ophthalmology; 2004 Oct 01; 111(10):1930-2. PubMed ID: 15465559
    [Abstract] [Full Text] [Related]

  • 20. Clinical benefit of chemosensitivity test for patients with regional lymph node-positive esophageal squamous cell carcinoma.
    Nakamori M, Iwahashi M, Nakamura M, Yamaue H.
    J Surg Oncol; 2003 Sep 01; 84(1):10-6. PubMed ID: 12949985
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.